Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location |
|---|---|---|---|
A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML |
FLT3-mutated Acute Myeloid Leukemia | Phase 2 | Turkey Jordan Germany Italy Czech Republic Poland Slovenia Korea, Republic of Japan Austria View All |
Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) |
CML, Chronic Myelogenous Leukemia, Leukemia, Myeloid Chronic, Hematologic Diseases | Phase 2 | United States France Czech Republic United Kingdom Spain Canada Taiwan Austria View All |
Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients |
Sickle Cell Disease (SCD) | Phase 2 | Turkey United States Spain Lebanon Germany Belgium Colombia United Kingdom Italy Canada Oman India France Brazil View All |
Dabrafenib and/or Trametinib Rollover Study |
Melanoma, Non Small Cell Lung Cancer, Solid Tumor, Rare Cancers, High Grade Glioma | Phase 4 | United States Spain Thailand |
Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors |
Advanced EGFRmutant NonSmallSellLungCancer (NSCLC),KRAS G12-mutant NSCLC,Esophageal SquamousCellCancer (SCC),Head/Neck SCC,Melanoma | Phase 1 | United States Netherlands Spain Japan Italy Korea, Republic of Singapore Taiwan Canada View All |
Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment Alone |
Advanced Solid Tumors Which Are cMET-dependent | Phase 2 | United States Canada Germany Belgium Italy Korea, Republic of Singapore View All |
Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study |
ALK Positive Malignancies | Phase 4 | Italy Brazil China Russian Federation Singapore France View All |
CAR-T Long Term Follow Up (LTFU) Study |
Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program | Not Applicable | United States Spain Germany Australia Japan Denmark Belgium Canada Finland United Kingdom Italy Norway France Singapore Taiwan Austria View All |
CINC424A2X01B Rollover Protocol |
Primary Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Acute Myeloid Leukemia, Thalassemia | Phase 4 | Japan Italy Korea, Republic of |
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis |
Multiple Sclerosis | Phase 3 | Serbia Romania Ukraine United Kingdom Spain France Australia View All |